임상시험

A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)

NCT: NCT05637801 · COMPLETED

NCT IDNCT05637801

상태COMPLETED

시작일2022-12-13

완료2026-08-17

SponsorCognito Therapeutics, Inc. (INDUSTRY)

First posted2022-12-05

Last updated2026-09-09

간략 요약

This is a randomized, double-blind, sham-controlled pivotal study of sensory stimulation in subjects with mild to moderate AD. Up to approximately 670 subjects will be treated with either Active or Sham investigational device, Spectris™ AD, for 60 minutes daily for approximately 12 months. Efficacy will be measured using the Integrated Alzheimer's Disease Mini-Mental State Exam (MMSE) Activities of Daily Living (ADCS-ADL) Rating Scale (iADMARS).

공식 출처

ClinicalTrials.gov에서 보기 →

데이터는 ClinicalTrials.gov API에서 제공됩니다. 최신 상태는 공식 기록을 확인하세요.